SEARCH · Engineering Papers

Results for “Optimized Building Performance”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

SourceResearch connectionFrom yearThrough year

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 37 records · Page 2

All sources NASA NTRS DOE OSTI

NASA NTRS1972

Concept for a high voltage solar array with integral power conditioning.

Description of a general case solution that synthesizes a high voltage solar array system from a switchable building block concept which makes possible system optimization for specific load requirements. A specific optimized solution is demonstrated, with performance estimates relating array area, weight, and power. Significant technology problems peculiar to a high-voltage switchable solar array design are discussed, along with special requirements anticipated during a hardware development effort.

Wiener, P.↗

NASA NTRSDate not supplied

Comparison of Artemis 2 and Artemis 5 Model Outcomes Using the Impact Probabilistic Risk Assessment Tool

BACKGROUND The Artemis campaign is a Moon exploration program with a series of six planned missions, five of which will be crewed. These five crewed missions will contain a single mission segment (space flight), or multiple mission segments involving space flight (Orion), lunar landing (LTV) and/or space habitat (Gateway). Each crewed segment faces the risk of unique medical conditions, necessitating medical sets/kits tailored to those specificities. To support and enable a data-driven and evidence-based decision-making process through out a mission’s life cycle, a software tool called IMPACT was developed. Using probabilistic risk assessment (PRA) methodologies, IMPACT (Informing Mission Planning via Analysis of Complex Tradespaces) is a novel tool built for analyzing the possibility of encountering complex medical risks during space flight, and for identifying the medical resources and capabilities needed to treat those potential at-risk medical conditions. This presentation will seek to compare IMPACT’s computational results upon potential complex space medical conditions (e.g., sprain/strain back or sleep disturbance) using IMPACT’s risk metrics and the associated optimized medical sets/kits between two Artemis missions: single segment Artemis 2 and multi-segmented Artemis 5. OVERVIEW By identifying potential medical conditions in space using input criteria such as crew quantity and composition, certain crew physical characteristics, mission duration and mission activities, IMPACT can produce analyses on the type of medical resources and capabilities needed to produce an optimized medical set/kit to address those medical conditions. IMPACT achieves this by performing hundreds of thousands of Monte Carlo simulations of missions to build aggregate pictures of medical risk. IMPACT’s risk metrics include loss of crew life (LOCL) – a measure of crew mortality due to medical conditions in space, return to definitive care (RTDC) – the need to perform crew evacuation, and task time lost (TTL) – a measure of the inability to perform activities due to crew disability. These risk metrics are applied to every medical condition identified by IMPACT’s computation analyses for every segment of the mission. Medical sets/kits are optimized to address these medical conditions but must fit within the stated Artemis Design Reference Mission (DRM) request for mass and volume physical size constraints. ANTICIPATED ANALYSIS AND CONCLUSION Using two Artemis missions, Artemis 2 and Artemis 5, IMPACT will provide the analyses for comparison of medical set/kit contents based upon mass and/or volume requirements and identify the at-risk medical conditions within both missions. This paper serves as an initial exploration of probabilistic risk assessment (PRA) medical risk calculations between two crewed Artemis missions and is not intended to be deemed the official medical response for the Artemis campaign.

probabilistic risk assessment↗

NASA NTRS2025

Assessment of Model Outcomes Between the Integrated Medical Model (IMM) and the Medical Extensible Dynamic Probabilistic Risk Assessment Tool (MEDPRAT)

The Medical Extensible Dynamic Probabilistic Risk Assessment Tool (MEDPRAT) is a computational model that provides human health and medical risk predictions for crewed spaceflight missions. MEDPRAT utilizes discrete event modeling and dynamic probabilistic simulation to predict critical mission outcomes (total medical events, crew health index, quality time lost, loss of crew life, removal to definitive care), condition occurrences, and resource consumption. Input parameters for MEDPRAT include crew attributes (e.g., sex), types of mission activities (e.g., whether and where crew members perform an extravehicular activity (EVA)), available resources, treatment information, and probability distributions for medical conditions. As an evolution of the Integrated Medical Model (IMM), MEDPRAT provides enhanced capabilities and higher fidelity, and incorporates more appropriate assumptions for long-duration spaceflight. IMM is the currently accepted standard for quantifying spaceflight mission medical risk in NASA operations that uses a probabilistic risk assessment (PRA) approach. MEDPRAT builds on the same logical foundation as IMM but implements the model architecture through highly optimized Monte Carlo sampling methods. An analysis is performed comparing the outputs from IMM with those from MEDPRAT V1.0 and V2.0 for the same reference missions in order to quantify similarities and differences in the model outcomes. The juxtaposition between IMM and MEDPRAT V1.0 and 2.0 shown in this report demonstrates that these two models generate very similar results; where differences in outcomes are shown, these are in accordance with the underlying assumptions and differences in the model architectures. This validation effort further establishes the credibility and reliability of the MEDPRAT software.

Matthew T Prelich↗

NASA NTRS2007

NASA Solar Sail Propulsion Technology Development

NASA's In-Space Propulsion Technology Program has developed the first generation of solar sail propulsion systems sufficient to accomplish inner solar system science and exploration missions. These first generation solar sails, when operational, will range in size from 40 meters to well over 100 meters in diameter and have an areal density of less than 13 grams per square meter. A rigorous, multi-year technology development effort culminated in 2005 with the testing of two different 20-m solar sail systems under thermal vacuum conditions. The first system, developed by ATK Space Systems of Goleta, California, uses rigid booms to deploy and stabilize the sail. In the second approach, L'Garde, Inc. of Tustin, California uses inflatable booms that rigidize in the coldness of space to accomplish sail deployment. This effort provided a number of significant insights into the optimal design and expected performance of solar sails as well as an understanding of the methods and costs of building and using them. In a separate effort, solar sail orbital analysis tools for mission design were developed and tested. Laboratory simulations of the effects of long-term space radiation exposure were also conducted on two candidate solar sail materials. Detailed radiation and charging environments were defined for mission trajectories outside the protection of the earth's magnetosphere, in the solar wind environment. These were used in other analytical tools to prove the adequacy of sail design features for accommodating the harsh space environment. Preceding and in conjunction with these technology efforts, NASA sponsored several mission application studies for solar sails. Potential missions include those that would be flown in the near term to study the sun and be used in space weather prediction to one that would use an evolved sail capability to support humanity's first mission into nearby interstellar space. This paper will describe the status of solar sail propulsion within NASA, nearterm solar sail mission applications, and near-term plans for further development.

Johnson, Les↗

NASA NTRS2006

Status of Solar Sail Propulsion: Moving Toward an Interstellar Probe

NASA's In-Space Propulsion Technology Program has developed the first-generation of solar sail propulsion systems sufficient to accomplish inner solar system science and exploration missions. These first-generation solar sails, when operational, will range in size from 40 meters to well over 100 meters in diameter and have an areal density of less than 13 grams-per-square meter. A rigorous, multiyear technology development effort culminated last year in the testing of two different 20-meter solar sail systems under thermal vacuum conditions. This effort provided a number of significant insights into the optimal design and expected performance of solar sails as well as an understanding of the methods and costs of building and using them. In a separate effort, solar sail orbital analysis tools for mission design were developed and tested. Laboratory simulations of the effects of long-term space radiation exposure were also conducted on two candidate solar sail materials. Detailed radiation and charging environments were defined for mission trajectories outside the protection of the earth's magnetosphere, in the solar wind environment. These were used in other analytical tools to prove the adequacy of sail design features for accommodating the harsh space environment. Preceding, and in conjunction with these technology efforts, NASA sponsored several mission application studies for solar sails, including one that would use an evolved sail capability to support humanity's first mission into nearby interstellar space. The proposed mission is called the Interstellar Probe. The Interstellar Probe might be accomplished in several ways. A 200-meter sail, with an areal density approaching 1 gram-per-square meter, could accelerate a robotic probe to the very edge of the solar system in just under 20 years from launch. A sail using the technology just demonstrated could make the same mission, but take significantly longer. Conventional chemical propulsion systems would require even longer flight times. Spinner sails of the type being explored by the Japanese may also be a good option, but the level of maturity in that technology is not clear. While the technology to support a 200-meter, ultralightweight sail mission is not yet in hand, the recent NASA investments in solar sail technology are an essential first step toward making it a reality. This paper will describe the status of solar sail propulsion within NASA, near-term solar sail mission applications, and the plan to advance the technology to the point where the Interstellar Probe mission can be flown.

Johnson, Les↗

NASA NTRS2007

Solar Sail Propulsion Technology at NASA

NASA's In-Space Propulsion Technology Program developed the first generation of solar sail propulsion systems sufficient to accomplish inner solar system science and exploration missions. These first generation solar sails, when operational, will range in size from 40 meters to well over 100 meters in diameter and have an area density of less than 13 grams per square meter. A rigorous, multi-year technology development effort culminated in 2005 with the testing of two different 20-m solar sail systems under thermal vacuum conditions. This effort provided a number of significant insights into the optimal design and expected performance of solar sails as well as an understanding of the methods and costs of building and using them. In addition, solar sail orbital analysis tools for mission design were developed and tested. Laboratory simulations of the effects of long-term space radiation exposure were also conducted on two candidate solar sail materials. Detailed radiation and charging environments were defined for mission trajectories outside the protection of the earth's magnetosphere, in the solar wind environment. These were used in other analytical tools to prove the adequacy of sail design features for accommodating the harsh space environment. The presentation will describe the status of solar sail propulsion within NASA, near-term solar sail mission applications, and near-term plans for further development.

Johnson, Charles Les↗

NASA NTRSDate not supplied

Vision 2030 Aircraft Propulsion Grand Challenge Problem: Full-engine CFD Simulations with High Geometric Fidelity and Physics Accuracy

2014 NASA published the outcome of the 2030 CFD (Computational Fluid Dynamics) Vision study: “CFD Vision 2030: A path to Revolutionary Computational Aerosciences” . The study provided a comprehensive review of the state of the art of CFD in 2014 for aerospace applications including, but not limited to, numerical algorithms, physics models, MDAO (Multidisciplinary Design Analysis and Optimization) and HPC (High Performance Computing) hardware. The study also proposed four conceptual ideas of Grand Challenge problems that would build on and benefit from advances outlined in the roadmap. The proposed challenges were meant to foster more detailed descriptions of grand challenge problems for specific disciplines. One of the proposed challenges was in the gas turbine propulsion area, focusing on transient full engine simulations. The current paper addresses detailed technical aspects of that challenge, and proposes a plan to approach it in a gradual manner, which includes high fidelity modeling of components, component coupling, and targeted experimental campaigns relying on common research models.

turbine engine↗

NASA NTRS1984

Positive Electrode Fabrication for Bi-polar Ni-h2 Cells

Bi-Polar nickel hydrogen design studies indicated a potential improvement in energy density and specific energy if positive electrodes could be manufactured in configurations of twice or more of the present normal thickness. Such electrodes would have to achieve similar active material loading, utilization, and cycle life to conventional 0.8mm I.P.U. nickel hydrogen electrodes. A capability for producing 1.0mm dry sinter and 1.5mm slurry sinter structures on production processes and equipment was demonstrated. The EPI/USAF electrochemical impregnation process proved capable of loading thick electrodes to 1.60 g/cubic centimeters void or higher. Sample electrodes incurred 2000 high rate stress cycles without significant structural or performance degradation. Formation regimes developed for thin plaque are not optimal for thick plaque and further investigation into electrode capacity build-up would seem warranted. Thick electrode technology development is continuing under other programs and shows promise of fulfilling the projected energy density and specific energy improvements.

Edgar, T. A.↗

NASA NTRS2006

Studies in Software Cost Model Behavior: Do We Really Understand Cost Model Performance?

While there exists extensive literature on software cost estimation techniques, industry practice continues to rely upon standard regression-based algorithms. These software effort models are typically calibrated or tuned to local conditions using local data. This paper cautions that current approaches to model calibration often produce sub-optimal models because of the large variance problem inherent in cost data and by including far more effort multipliers than the data supports. Building optimal models requires that a wider range of models be considered while correctly calibrating these models requires rejection rules that prune variables and records and use multiple criteria for evaluating model performance. The main contribution of this paper is to document a standard method that integrates formal model identification, estimation, and validation. It also documents what we call the large variance problem that is a leading cause of cost model brittleness or instability.

data mining↗

NASA NTRS1993

Effect of design selection on response surface performance

The mathematical formulation of the engineering optimization problem is given. Evaluation of the objective function and constraint equations can be very expensive in a computational sense. Thus, it is desirable to use as few evaluations as possible in obtaining its solution. In solving the equation, one approach is to develop approximations to the objective function and/or restraint equations and then to solve the equation using the approximations in place of the original functions. These approximations are referred to as response surfaces. The desirability of using response surfaces depends upon the number of functional evaluations required to build the response surfaces compared to the number required in the direct solution of the equation without approximations. The present study is concerned with evaluating the performance of response surfaces so that a decision can be made as to their effectiveness in optimization applications. In particular, this study focuses on how the quality of approximations is effected by design selection. Polynomial approximations and neural net approximations are considered.

Carpenter, William C.↗

NASA NTRS2019

Design Optimization for X-Ray Telescopes

The capability of future X-ray telescopes depends on the quality of their Point Spread Function (PSF) and the size of their field of view. Traditional designs, such as Wolter, and Wolter-Schwarzschild telescopes are stigmatic on the optical axis but their PSF degrades rapidly off-axis. At the optimal focal surface, their PSFs can be significantly improved. We present a simple optimization process for Wolter (W), Wolter-Schwarzschild (WS) and Hyperboloid-Hyperboloid (HH) telescopes that substantially improves the off-axis PSF for either narrow or wide field of view applications. In this paper, we will compare the optical performance of conventional and optimized W-, WS-, and HH-telescopes for a wide range of telescope diameters that can be used to build up future x-ray telescopes.

Saha, Timo T.↗

NASA NTRS2019

Design Optimization for X-Ray Telescopes

Saha, Timo T.↗

NASA NTRS2019

Design Optimization for X-ray Telescopes

Timo T Saha↗

NASA NTRS1993

Optimization of knowledge-based systems and expert system building tools

The objectives of the NASA-AMES Cooperative Agreement were to investigate, develop, and evaluate, via test cases, the system parameters and processing algorithms that constrain the overall performance of the Information Sciences Division's Artificial Intelligence Research Facility. Written reports covering various aspects of the grant were submitted to the co-investigators for the grant. Research studies concentrated on the field of artificial intelligence knowledge-based systems technology. Activities included the following areas: (1) AI training classes; (2) merging optical and digital processing; (3) science experiment remote coaching; (4) SSF data management system tests; (5) computer integrated documentation project; (6) conservation of design knowledge project; (7) project management calendar and reporting system; (8) automation and robotics technology assessment; (9) advanced computer architectures and operating systems; and (10) honors program.

Yasuda, Phyllis↗

NASA NTRSDate not supplied

Lightweight Thrust Chamber Assemblies using Multi-Alloy Additive Manufacturing and Composite Overwrap

Additive Manufacturing (AM) has brought significant design and fabrication opportunities for complex components with internal features such as liquid rocket engine thrust chambers not previously possible. This technology allows for significant cost savings and schedule reductions in addition to new performance optimization through weight reduction and increased margins. Specific to regeneratively-cooled combustion chambers and nozzles for liquid rocket engines, additive manufacturing offers the ability to form the complex internal coolant channels and the closeout of the channels to contain the high pressure liquid propellants with a single operation. Much of additive manufacturing development has focused on monolithic alloys using Laser Powder Bed Fusion (L-PBF), which do not allow for complete optimization of the structure. The National Aeronautics and Space Administration (NASA) completed feasibility of an AM bimetallic L-PBF GRCop-84 copper-alloy combustion chamber with an AM electron beam freeform Inconel 625 structural jacket under the Low Cost Upper Stage Propulsion (LCUSP) Project. A follow-on project called Rapid Analysis and Manufacturing Propulsion Technology (RAMPT) is under development to further expand large-scale multi-alloy thrust chambers while maturing composite overwrap technology for significant weight savings opportunities. The RAMPT project has three primary objectives: 1) Advancing blown powder Directed Energy Deposition (DED) to fabricate integral-channel large scale nozzles, 2) Develop composite overwrap technology to reduce weight and provide structural capability for thrust chamber assemblies, and 3) Develop bimetallic and multi-metallic additively manufactured radial and axial joints to optimize material performance. In addition to these primary manufacturing developments, analytical modeling efforts compliment the process development to simulate the AM processes to reduce build failures and distortions. The RAMPT project is also maturing the supply chain for various manufacturing processes described above in addition to L-PBF of GRCop-42. This paper will present an overview of the RAMPT project, the process development and hardware progress to date, material and hot-fire testing results, along with future developments.

Additive Manufacturing↗

NASA NTRSDate not supplied

Improving Efficacy and Safety of Pharmacological Treatment Through Precision Medicine and Pharmacogenomics for Human Deep Space Exploration

INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expanding duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be even more essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to further tailor medications included in the spacecraft formulary and increased examination of appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of cutting-edge research and medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique factors and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. One example is the field of pharmacogenomics (PGX),the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on pharmaceutical choice and dosing to avoid adverse drug events and maximize pharmacological efficacy. The goal of this study was to evaluate which drugs in the current space pharmacy could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs onboard the International Space Station (ISS) was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both personal astronaut medications, including supplements and over the counter drugs (n=151) and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in 157 total drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure. Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent adverse events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost or technical and ranked from 1 (very low) to 5 (very high).A comprehensive assessment of commercially available PGX solutions is currently underway to evaluate specimen requirements, cost/benefit analysis (cost vs. number of alleles assessed), utility of variant analysis, relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments(LxC 5x5 table) indicated29medicationswere in the yellow or red zone driven predominantly by drug failure or safety concerns, with the remainder(n=128)of the medications in the green zone where risk is acceptable. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive pre-flight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve targeting drug efficacy and safety, and further open the door to countermeasure research exploring PGX-related allelic variants. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more cost effective and more efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing crew autonomy and providing tailored countermeasures

Alice R W Tang↗

NASA NTRSDate not supplied

Improving Efficacy and Safety of Pharmacological Treatment Through Precision Health and Pharmacogenomics

INTRODUCTION: Future spaceflight will require increased crew medical autonomy as exploration class missions expand in duration and distance from Earth, especially for Mars missions. As mission duration increases, it will be essential to have appropriate amounts of effective medication to ensure the maintenance of crew health and performance. Conversely, mass and volume constraints will become more severe as future spaceflight expands beyond low Earth orbit, where resupply is difficult or becomes impossible. These constraints thus convey an urgency to tailor medications for individual crewmembers and further examine appropriate dosing regimens. BACKGROUND: Precision Health is an exciting area of medicine focused on maintaining an individual’s health and performance through in-depth understanding of an individual’s unique clinical and environmental history, genetic makeup, and molecular profiles. This approach can be adapted to better predict, monitor, and address physiological responses to the spaceflight environment. A subset of this field is pharmacogenomics (PGX), the study of how the expressed genome impacts drug responses with the goal of prescribing the right dose of the right drug at the right time. Specifically, PGX testing provides valuable information on an individual’s precise allelic variations to guide physicians in making informed decisions on drug choice and dosing to avoid adverse events and maximize efficacy. The study goal was to identify which current space pharmacy drugs could be evaluated using PGX testing and to understand the potential impact on the health and wellness of the astronaut population. Additionally, we sought to evaluate clinically available FDA-approved PGX testing solutions to better understand its applicability. METHODS: A complete list of drugs on the ISS was analyzed for risk and likelihood of drug failure and PGX actionability. This analysis encompassed both astronauts’ personal medications, including supplements and over the counter drugs (n=151) contained in the ISS medical accessory kit (IMAK), and ISS MedKit formulary medications (n=95). Duplicate medications and different formulations were removed, which resulted in a total of 157 drugs used in the subsequent analysis. A 5x5 risk assessment table was produced by examining the likelihood of drug failure compared to the consequence of drug failure (LxC). Likelihood of individual drug failure was defined by whether existing processes are sufficient to prevent ineffective treatment or impactful side effect events, as ranked from 1 (very low, can easily be prevented) to 5 (very high, cannot be prevented) during a Mars mission. In contrast, the consequence of drug failure was defined by impact to safety, schedule, cost, or technical criteria and ranked from 1 (very low) to 5 (very high). An assessment of PGX reference laboratories is currently underway to evaluate sample requirements, benefit analysis (cost vs. utility of allele variant analysis), relevance to inflight medication usage, quality of reporting in enabling clinical application, and ease of integration into electronic medical records. RESULTS: Risk assessments (LxC 5x5 table) indicated 128 medications were in the green zone where risk is acceptable, with the remaining 29 of the medications in the yellow or red zone driven predominantly due to drug failure or safety concerns. We found that current PGX testing results could impact 21% of the total medications in the ISS MedKit and IMAK; of these, 9 medications currently have direct clinically actionable guidance available. Results of the clinical PGX solution evaluations as related to these medications will be presented. CONCLUSION: PGX testing has demonstrated clear benefits in terrestrial medicine and clinical environments for the selection of proper medications, avoiding adverse drug reactions, and maximizing drug efficacy. We propose that similar benefits would be bestowed on the astronaut and commercial spaceflight passenger population by performing preemptive preflight PGX testing to reduce risk of mission failure due to ineffective or toxic medications, improve drug efficacy, and further open the door to countermeasure research. For example, PGX results could allow tailoring of specific medications at optimal doses more precisely to each individual astronaut, particularly in areas of space motion sickness, sleep aids, and analgesics. An additional benefit is that PGX results could provide information for better planning of the components of a space pharmacy for deep space missions to be more effective and efficient in the utilization of limited pharmaceutical resources. Finally, while PGX testing of the astronaut corps is not currently conducted, this approach could provide immediate impact in support of mission success by reducing risks, optimizing astronaut performance, and providing valuable insights into long-term astronaut health. Such advancements in clinical decision making are important next steps in building dynamic individual risk profiles for astronauts, increasing selection of the best treatment choice, and providing tailored countermeasures for individual crewmembers.

Pharmacogenomics↗

NASA NTRSDate not supplied

Autonomous In-space Construction, Maintenance, and Reconfiguration Using Programmable Meta-Material

NASA ARC's Coded Structures Laboratory (CSL) is developing autonomous construction, maintenance, and reconfiguration technologies to meet long-duration and deep space infrastructure needs, in accordance with long-term NASA goals of "in-space reliance" and "mass-less exploration." We seek to achieve these capabilities by utilizing a "programmable meta-material" approach that integrates emerging advances in materials (mechanical meta-materials), manufacturing (cooperative mobile robotics), and autonomy (multi-agent planning algorithms). Through the ARMADAS project, we have shown assembly of high-performance engineered cellular materials using multiple cooperating mobile robotic assemblers. In this paper, we describe how such a programmable meta-material architecture may shift the paradigm of how we design, build, manufacture, and operate future space infrastructure and assets. The core of a programmable meta-material architecture consists of 3 main technology sub-areas: the structure, the assembly agents, and the assembly algorithms. We co-design these systems to ensure an adaptable system that can create and reconfigure structures from a base set of building block components. From this core technology, we can branch out and expand the capability of the system through additional secondary component types and robotic agents to perform activities such as inspections, maintenance, repair, payload installation, or perform power and communications interconnect. As these technologies mature, future designers will be able to utilize the system to rapidly integrate and operate assets in space or on planetary surfaces from a set of well-tested part library, or create their own modules to integrate into the system. A core trait to the development of this system is the automation approach. Because of the modular and functional discrete (pixel-like) nature of the structural system, a diverse set of powerful algorithms for analysis, planning, and simulation can be adapted and leveraged to optimize construction, maintenance, and dynamic reorganization (as hardware with programmable form and function). With an ability to free the design space from launch vehicle constraints and fundamentally shift how a mission is designed and conducted, we discuss the influence of a programmable meta-material architecture on mission design, build, and operations. For the "design phase", we discuss project lifecycle effects, costs, time, and performance. For the "build phase", we discuss reusability, ISRU, manufacturing, material logistics, and scalability. And for "operations", we discuss autonomy, maintenance and upgrades, reliability, and reconfiguration. Autonomy and modularity are the primary enabling traits of this system. Engineering systems that utilize a modular and reconfiguration building block approach such as digital communication and computation systems, currently lead all other areas of technology in size and complexity scalability. NASA is extending the benefits and flexibility of digital systems to hardware systems, to optimize materials lifecycle management and expand our space exploration mission capabilities.

in space assembly↗